NCT05156749 Short and Long-arm Fiberglass Cast Immobilization for Distal Salter Harris I and II Forearm Fractures in Children
| NCT ID | NCT05156749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Children's Hospital, Zurich |
| Condition | Fracture Forearm |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2021-12-07 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2021-12-07 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate whether short-arm fiberglass cast (SAC) immobilization provides fracture stabilization comparable to that of long-arm cast (LAC) treatment of displaced and non-displaced distal Salter Harris I/II forearm fractures in paediatric patients.
Eligibility Criteria
Inclusion Criteria: * Salter Harris I or II fracture of the distal radius or a forearm fracture * informed consent Exclusion Criteria: * open/instable/intraarticular fracture * age \<4 years or \> 16years * no informed consent
Contact & Investigator
Michelle Seiler, PD
STUDY CHAIR
University Children's Hospital, Zurich
Frequently Asked Questions
Who can join the NCT05156749 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 16 Years, studying Fracture Forearm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05156749 currently recruiting?
Yes, NCT05156749 is actively recruiting participants. Contact the research team at michelle.seiler@kispi.uzh.ch for enrollment information.
Where is the NCT05156749 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT05156749 clinical trial?
NCT05156749 is sponsored by University Children's Hospital, Zurich. The principal investigator is Michelle Seiler, PD at University Children's Hospital, Zurich. The trial plans to enroll 120 participants.